-
Paeoniflorin and Tmem176b+ Macrophages in Liver I/R
2026-08-28
This 2025 study combines single-cell RNA sequencing with pharmacological and macrophage-depletion experiments to identify Tmem176b+ macrophages as a key cellular target of paeoniflorin in hepatic ischemia-reperfusion injury. Its findings connect macrophage phenotypic remodeling with the THBS1-CD47 and SPP1-CD44 signaling axes, providing a mechanistic framework for studying immune regulation during liver injury.
-
AI-10-49 Workflows for inv(16) AML Research
2026-08-28
AI-10-49 enables mechanism-led interrogation of the CBFβ-SMMHC/RUNX1 axis, linking fusion-protein disruption to chromatin, transcriptional, and survival readouts. This practical guide covers dose finding, target-engagement assays, chromatin immunoprecipitation, MYCN/eIF4G1 analysis, and in vivo leukemia model design.
-
VX-745 for Reproducible Cell Assays
2026-08-27
Learn how VX-745, SKU A8686, can help researchers interpret viability, proliferation, and inflammatory readouts through selective p38α MAPK inhibition. This scenario-based guide covers assay compatibility, dosing, controls, data interpretation, and practical product-selection criteria.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-08-27
The reference study identifies MDM1 as a regulator of p53 expression and apoptosis that influences colorectal cancer sensitivity to chemoradiotherapy. Its combination of genetic perturbation, RNA sequencing, mechanistic promoter analysis, and xenograft testing supports MDM1 as a candidate predictive biomarker, while also suggesting that apoptosis-directed interventions may help investigate treatment resistance.
-
Diuron: Mechanism, Renal Toxicology & Workflow
2026-08-26
Diuron, also known as 3-(3,4-dichlorophenyl)-1,1-dimethylurea, is a phenylurea photosynthesis inhibitor used in plant biology research and toxicology. Current evidence links experimental Diuron exposure to JAK2/STAT1 pathway activation and acute kidney injury phenotypes in an integrated network-toxicology and HK-2-cell study.
-
MitMAB for Organoid Endocytosis Research
2026-08-26
MitMAB enables mechanism-focused testing of dynamin-dependent vesicle scission in intestinal organoid and extracellular-vesicle uptake assays. This guide translates recent intestinal stem cell model findings into practical dosing, controls, readouts, and troubleshooting strategies.
-
Clarithromycin CYP3A Inhibitor Workflows
2026-08-25
Build more interpretable drug-drug interaction research with Clarithromycin, a practical CYP3A inhibitor for controlled metabolism and pharmacokinetic studies. This guide combines solvent handling, concentration design, pathway controls, and troubleshooting for statin and cardiovascular disease drug interaction models.
-
Toremifene Citrate: ER Assay Workflow Guide
2026-08-25
Build more interpretable estrogen receptor experiments with a concentration-aware workflow for receptor binding, MCF-7 proliferation, and pathway analysis. This guide combines practical assay controls with comparative insight from the toremifene-versus-tamoxifen evidence base.
-
TUNEL Apoptosis Detection Kit for Glioma Studies
2026-08-24
Learn how to apply DAB-based TUNEL staining to cultured glioma cells and tissue sections, connecting DNA fragmentation with treatment response and tissue morphology. The workflow combines practical controls, optimization guidance, and a glioma-focused interpretation framework based on recent network pharmacology and experimental findings.
-
HyperScript™ Reverse Transcriptase for RNA Assays
2026-08-24
Learn how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when adipose-tissue transcripts are long, structured, or scarce. This article translates new Netrin-1 biology into practical cDNA synthesis for qPCR and assay-validation decisions.
-
GSK126 and the Next Generation of EZH2 Translation
2026-08-23
A translational framework for using GSK126 to connect PRC2 biology, H3K27me3 pharmacodynamics, cancer epigenetics research, and emerging EZH2 degradation insights.
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-22
The Annexin V-APC/7-AAD Apoptosis Kit connects phosphatidylserine exposure with membrane-integrity analysis for rigorous apoptosis and necrosis detection. This guide explains how to interpret the assay alongside mechanistic studies of epigenetic drug response, including MLL-rearranged leukemia research.
-
Rosiglitazone: Designing Better Adipose Assays
2026-08-21
Rosiglitazone and Brl-49653 provide a precise way to interrogate PPARγ biology. This guide develops a comparative assay framework that separates adipogenesis, insulin sensitivity modulation, and beige-fat thermogenesis using recent SEMA3E research.
-
SR 11302: AP-1 Transcription Factor Inhibitor Guide
2026-08-20
SR 11302 enables selective interrogation of AP-1-driven proliferation, tumor promotion, and macrophage-associated cancer biology without activating retinoid receptors. This practical guide connects cell-based dose–response assays with the TLR4–macrophage framework reported in colitis-associated colorectal cancer research.
-
Engineered Klotho mRNA Reverses Senescence in iMSCs
2026-08-20
The reference study combines engineered, non-integrating Klotho mRNA with hyperbranched poly(β-amino ester) delivery to address senescence in Klotho-deficient and aged induced mesenchymal stem cells. Its findings connect restored Klotho expression with improved mitochondrial function, reduced oxidative stress, normalized calcium homeostasis, and selective recovery of older or Klotho-deficient cells.